Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide

腺苷酸激酶 环化酶 单克隆抗体 肽 化学 垂体腺苷酸环化酶激活肽 抗体 药理学 生物化学 生物 免疫学 神经肽 酶 血管活性肠肽 受体
作者
Cristina Moldovan Loomis,Benjamin Dutzar,Ethan W. Ojala,Lee Hendrix,Charlie Karasek,Michelle L. Scalley-Kim,Jenny Mulligan,Pei Fan,Jens Billgren,Vanessa Rubin,Heidi Boshaw,Gayle Kwon,Sam Marzolf,Erica Stewart,David Jurchen,Susan M. Pederson,Lisa Perrino McCulloch,Brian Baker,Roger K. Cady,John A Latham
出处
期刊:Journal of Pharmacology and Experimental Therapeutics [American Society for Pharmacology and Experimental Therapeutics]
卷期号:369 (1): 26-36 被引量:60
标识
DOI:10.1124/jpet.118.253443
摘要

Migraine is a debilitating disease that affects almost 15% of the population worldwide and is the first cause of disability in people under 50 years of age, yet its etiology and pathophysiology remain incompletely understood. Recently, small molecules and therapeutic antibodies that block the calcitonin gene-related peptide (CGRP) signaling pathway have reduced migraine occurrence and aborted acute attacks of migraine in clinical trials and provided prevention in patients with episodic and chronic migraine. Heterogeneity is present within each diagnosis and patient's response to treatment, suggesting migraine as a final common pathway potentially activated by multiple mechanisms, e.g., not all migraine attacks respond to or are prevented by anti-CGRP pharmacological interventions. Consequently, other unique mechanisms central to migraine pathogenesis may present new targets for drug development. Pituitary adenylate cyclase-activating peptide (PACAP) is an attractive novel target for treatment of migraines. We generated a specific, high-affinity, neutralizing monoclonal antibody (ALD1910) with reactivity to both PACAP38 and PACAP27. In vitro, ALD1910 effectively antagonizes PACAP38 signaling through the pituitary adenylate cyclase-activating peptide type I receptor, vasoactive intestinal peptide receptor 1, and vasoactive intestinal peptide receptor 2. ALD1910 recognizes a nonlinear epitope within PACAP and blocks its binding to the cell surface. To test ALD1910 antagonistic properties directed against endogenous PACAP, we developed an umbellulone-induced rat model of neurogenic vasodilation and parasympathetic lacrimation. In vivo, this model demonstrates that the antagonistic activity of ALD1910 is dose-dependent, retaining efficacy at doses as low as 0.3 mg/kg. These results indicate that ALD1910 represents a potential therapeutic antibody to address PACAP-mediated migraine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
高大抽屉发布了新的文献求助10
2秒前
2秒前
2秒前
敏感若云完成签到 ,获得积分10
2秒前
3秒前
楊子完成签到,获得积分10
3秒前
Ronedler发布了新的文献求助10
4秒前
5秒前
情怀的应助被高大抽屉采纳,获得10
6秒前
科研通AI6.2的应助被第一作者采纳,获得10
6秒前
小蘑菇的应助被张冠黄戴采纳,获得10
6秒前
秋风的应助被陶醉冥王星采纳,获得10
6秒前
bean的应助被芦苇采纳,获得10
7秒前
薄荷水发布了新的文献求助10
7秒前
张飞完成签到,获得积分10
8秒前
Orange的应助被老大车采纳,获得10
8秒前
8秒前
9秒前
阿申爱乐的应助被姚永恒采纳,获得30
9秒前
迅速的念芹完成签到 ,获得积分10
10秒前
sunnymoon发布了新的文献求助10
10秒前
10秒前
脑洞疼的应助被咿呀采纳,获得10
11秒前
tree完成签到,获得积分10
11秒前
11秒前
11秒前
12秒前
如是r完成签到,获得积分10
13秒前
14秒前
Maestro_S的应助被美满的画板采纳,获得30
14秒前
14秒前
chen01hang的应助被bff采纳,获得10
15秒前
sunnymoon发布了新的文献求助10
15秒前
Akim的应助被艾格采纳,获得10
16秒前
17秒前
大气幻柏发布了新的文献求助10
17秒前
dolla完成签到 ,获得积分10
17秒前
wuang完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188221
求助须知:如何正确求助?哪些是违规求助? 9576025
关于积分的说明 21845049
捐赠科研通 7786165
什么是DOI,文献DOI怎么找? 3435226
关于科研通互助平台的介绍 2559559
邀请新用户注册赠送积分活动 2482157